Risedronate improves bone mineral density in Crohn's disease: A two year randomized controlled clinical trial

Risedronate, in addition to daily calcium and vitamin D supplementation, is superior to calcium and vitamin D alone in improving femoral trochanter and total hip BMD in patients with Crohn's disease.